World's Best Scientists 2026 revealed!
Francisco Antunes

Francisco Antunes

D-Index & Metrics

Microbiology

D-Index
50
Citations
8868
World Ranking
4460
National Ranking
14

Overview

Francisco Antunes is affiliated with the University of Lisbon in Portugal and specializes primarily in the field of Medicine. Their research spans various subfields, including Epidemiology, Infectious Diseases, Virology, Food Science, and Molecular Biology.

The scientist's work focuses on several key topics:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • HIV/AIDS research and interventions
  • HIV, drug use, and sexual risk
  • Poxvirus research and outbreaks
  • Bacillus and Francisella bacterial research
  • Herpesvirus infections and treatments

Frequent co-authors in their research include Ana Virgolino, Raquel Sabino, Fernando Maltêz, Cristina Veríssimo, and Álvaro Pereira.

Publications have appeared across multiple journals, with frequent venues being the International Journal of Environmental Research and Public Health, Frontiers in Public Health, Healthcare, HIV Medicine, and Microorganisms.

Recent publications exemplify the scope of their research:

  • "Candida Auris, An Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?" (2020) in Microorganisms
  • "Monkeypox: From A Neglected Tropical Disease to a Public Health Threat" (2022) in Infectious Disease Reports
  • "Handling of Fresh Vegetables: Knowledge, Hygienic Behavior of Vendors, Public Health in Maputo Markets, Mozambique" (2020) in International Journal of Environmental Research and Public Health
  • "Persistence of IgG COVID-19 antibodies: A longitudinal analysis" (2023) in Frontiers in Public Health
  • "Towards a Global Perspective of Environmental Health: Defining the Research Grounds of an Institute of Environmental Health" (2020) in Sustainability

Best Publications

  • Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

    Deborah Konopnicki;Amanda Mocroft;S. De Wit;Francisco Antunes

  • Subgenotype Analysis of Cryptosporidium Isolates from Humans, Cattle, and Zoo Ruminants in Portugal

    Margarida Alves;Lihua Xiao;Irshad Sulaiman;Altaf A. Lal

  • AIDS across Europe, 1994–98: the EuroSIDA study

    A Mocroft;C Katlama;AM Johnson;C Pradier

  • Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.

    Mocroft A;Brettle R;Kirk O;Blaxhult A

  • A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

    Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper

  • Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

    Ole Kirk;Court Pedersen;Alessandro Cozzi-Lepri;Francisco Antunes

  • Changing incidence of central nervous system diseases in the EuroSIDA cohort

    Antonella D'Arminio Monforte;Paola Cinque;Amanda Mocroft;Frank Detlev Goebel

  • A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

    Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  • Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal.

    Margarida Alves;Lihua Xiao;Francisco Antunes;Olga Matos

  • Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA study.

    V Miller;A Mocroft;P Reiss;C Katlama

  • Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results

    Jose Gatell;Dominique Salmon Ceron;Adriano Lazzarin;Eric Van Wijngaerden

  • Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.

    Joanne Reekie;Csaba Kosa;Frederik Engsig;Antonella d'Arminio Monforte

  • The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: The EuroSIDA study

    Amanda Mocroft;Ole Kirk;Nathan Clumeck;Panaglotis Gargalianos-Kakolyris

  • Human immunodeficiency virus type 2 (HIV-2) in Portugal: clinical spectrum, circulating subtypes, virus isolation, and plasma viral load.

    Vincent Soriano;Perpétua Gomes;Walid Heneine;Africa Holguín

  • Epidemiology of AIDS dementia complex in Europe

    A. Chiesi;S. Vella;L. G. Dally;C. Pedersen

  • Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results

    Joel E. Gallant;Ellen Koenig;Jaime Andrade-Villanueva;Ploenchan Chetchotisakd

  • Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.

    Alessandro Cozzi-Lepri;Andrew N Phillips;Lidia Ruiz;Bonaventura Clotet

  • Microsporidia as emerging pathogens and the implication for public health: a 10-year study on HIV-positive and -negative patients.

    Maria Luísa Lobo;Lihua Xiao;Francisco Antunes;Olga Matos

  • Nevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN Trial.

    Vicente Soriano;Keikawus Arasteh;Horacio Migrone;Thomas Lutz

  • Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind?

    Raquel Filipa Pinheiro Sabino;Cristina Veríssimo;Cristina Veríssimo;Álvaro Ayres Pereira;Francisco Antunes

  • Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy.

    Berta Rodés;Africa Holguín;Vincent Soriano;Manuela Dourana

  • Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

    Pedro Cahn;Jorge Villacian;Adriano Lazzarin;Christine Katlama

Frequent Co-Authors

Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Amanda Mocroft
Amanda Mocroft University College London
Andrzej Horban
Andrzej Horban Medical University of Warsaw
Lihua Xiao
Lihua Xiao South China Agricultural University
Christine Katlama
Christine Katlama Sorbonne University
José M. Gatell
José M. Gatell University of Barcelona
Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Nathan Clumeck
Nathan Clumeck Université Libre de Bruxelles
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
Juan González-Lahoz
Juan González-Lahoz Instituto de Salud Carlos III

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to a variety of related online degrees and career pathways, especially for those looking to pivot within the healthcare or science fields. For individuals with unique circumstances, options like college degrees for felons provide accessible avenues to build new careers in science and healthcare.

One promising path includes roles in healthcare that blend science with patient care. Becoming a functional medicine nurse practitioner, for example, offers a competitive salary while allowing professionals to apply a science-based holistic approach to health.

Alternatively, many graduates pursue careers in healthcare administration or medical information management. The cpc medical coding salary reflects the growing demand for expertise in medical coding, an essential role in medical billing and records. Similarly, a role in healthcare information management salary underscores the increasing importance of managing patient data and healthcare systems efficiently.

Exploring these diverse career paths highlights the flexibility of a microbiology background paired with targeted online degrees, supporting both clinical and administrative roles in the broader healthcare industry.

Best Scientists Citing Francisco Antunes

Trending Scientists